These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20541258)

  • 1. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar.
    Várkonyi T; Nagy B; Füle T; Tarca AL; Karászi K; Schönléber J; Hupuczi P; Mihalik N; Kovalszky I; Rigó J; Meiri H; Papp Z; Romero R; Than NG
    Placenta; 2011 Feb; 32 Suppl(0):S21-9. PubMed ID: 20541258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.
    Szabo S; Mody M; Romero R; Xu Y; Karaszi K; Mihalik N; Xu Z; Bhatti G; Fule T; Hupuczi P; Krenacs T; Rigo J; Tarca AL; Hassan SS; Chaiworapongsa T; Kovalszky I; Papp Z; Than NG
    Pathol Oncol Res; 2015 Jul; 21(3):659-68. PubMed ID: 25583406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis of placentae reveals HELLP syndrome exhibits a greater extent of placental metabolic dysfunction than preeclampsia.
    Gong L; Zhao H; Cui Y; Li X
    Hypertens Pregnancy; 2021 May; 40(2):134-143. PubMed ID: 33818250
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion?
    Karaszi K; Szabo S; Juhasz K; Kiraly P; Kocsis-Deak B; Hargitai B; Krenacs T; Hupuczi P; Erez O; Papp Z; Kovalszky I; Than NG
    Placenta; 2019 Jan; 76():30-39. PubMed ID: 30803712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven placental transcripts characterize HELLP-syndrome.
    Buimer M; Keijser R; Jebbink JM; Wehkamp D; van Kampen AH; Boer K; van der Post JA; Ris-Stalpers C
    Placenta; 2008 May; 29(5):444-53. PubMed ID: 18374411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.
    Szabo S; Xu Y; Romero R; Fule T; Karaszi K; Bhatti G; Varkonyi T; Varkonyi I; Krenacs T; Dong Z; Tarca AL; Chaiworapongsa T; Hassan SS; Papp Z; Kovalszky I; Than NG
    Virchows Arch; 2013 Sep; 463(3):445-58. PubMed ID: 23807541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The placental component and obstetric outcome in severe preeclampsia with and without HELLP syndrome.
    Weiner E; Schreiber L; Grinstein E; Feldstein O; Rymer-Haskel N; Bar J; Kovo M
    Placenta; 2016 Nov; 47():99-104. PubMed ID: 27780546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome.
    Balogh A; Pozsgay J; Matkó J; Dong Z; Kim CJ; Várkonyi T; Sammar M; Rigó J; Meiri H; Romero R; Papp Z; Than NG
    Am J Obstet Gynecol; 2011 Aug; 205(2):156.e1-14. PubMed ID: 21596368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinicohistopathologic comparison between HELLP syndrome and severe preeclampsia.
    Smulian J; Shen-Schwarz S; Scorza W; Kinzler W; Vintzileos A
    J Matern Fetal Neonatal Med; 2004 Nov; 16(5):287-93. PubMed ID: 15621545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.
    Fruscalzo A; Schmitz R; Klockenbusch W; Köhler G; Londero AP; Siwetz M; Huppertz B
    Histochem Cell Biol; 2012 Dec; 138(6):925-32. PubMed ID: 22847813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.
    Stepan H; Leo C; Purz S; Höckel M; Horn LC
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):172-6. PubMed ID: 16219518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe preeclampsia with and without HELLP differ with regard to placental pathology.
    Vinnars MT; Wijnaendts LC; Westgren M; Bolte AC; Papadogiannakis N; Nasiell J
    Hypertension; 2008 May; 51(5):1295-9. PubMed ID: 18362224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic aspects of preeclampsia and the HELLP syndrome.
    Haram K; Mortensen JH; Nagy B
    J Pregnancy; 2014; 2014():910751. PubMed ID: 24991435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of placental pathology between severe preeclampsia and HELLP syndrome.
    Mehrabian F; Mohammadizadeh F; Moghtaderi N; Najafian A
    Arch Gynecol Obstet; 2012 Jan; 285(1):175-81. PubMed ID: 21698449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical features and pregnancy outcomes in early- and late-onset preeclampsia with HELLP syndrome: a 10-year retrospective study from a tertiary hospital and referral center in China.
    Li B; Yang H
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):186. PubMed ID: 35260082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of Placental Protein 1 (PP1), PP8, and PP22 and characterization of their placental expression in healthy pregnancies and in preeclampsia.
    Szabo S; Karaszi K; Romero R; Toth E; Szilagyi A; Gelencser Z; Xu Y; Balogh A; Szalai G; Hupuczi P; Hargitai B; Krenacs T; Hunyadi-Gulyas E; Darula Z; Kekesi KA; Tarca AL; Erez O; Juhasz G; Kovalszky I; Papp Z; Than NG
    Placenta; 2020 Sep; 99():197-207. PubMed ID: 32747003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of differentially expressed genes in placental tissues of early-onset severe preeclampsia patients].
    Song Y; Yang J; Liu J; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):501-5. PubMed ID: 25327731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker.
    Zadora J; Singh M; Herse F; Przybyl L; Haase N; Golic M; Yung HW; Huppertz B; Cartwright JE; Whitley G; Johnsen GM; Levi G; Isbruch A; Schulz H; Luft FC; Müller DN; Staff AC; Hurst LD; Dechend R; Izsvák Z
    Circulation; 2017 Nov; 136(19):1824-1839. PubMed ID: 28904069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome.
    Knerr I; Dachert C; Beinder E; Metzler M; Dötsch J; Repp R; Rascher W
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):47-53. PubMed ID: 11905404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome.
    van Rijn BB; Franx A; Steegers EA; de Groot CJ; Bertina RM; Pasterkamp G; Voorbij HA; Bruinse HW; Roest M
    PLoS One; 2008 Apr; 3(4):e1865. PubMed ID: 18382655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.